Who depends on License Two
1 listed supplier reports License Two as a customer worth 10% or more of their revenue, led by Abvc Biopharma at 39%.
Get an email when License Two's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on License Two
Listed companies whose annual report names License Two as a customer worth 10% or more of their revenue. If License Two cuts orders or switches supplier, these are the companies that feel it.
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Abvc BiopharmaABVC | 39% | new | 1 year | FY 2024 · filed 3 Mar 2026 |
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Research FrontiersREFR | 18% | last FY 2021 | 2 years | FY 2021 · filed 9 Mar 2022 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API